Skin conditions (dermatitis, eczema, psoriasis) Board decisions

The Board denied service connection for bilateral pes planus and pseudofolliculitis barbae as there is no evidence linking these conditions to the Veteran's active military service.

The Board denied service connection for a right knee disability, chronic sinusitis, dermatitis, cephalgia, and an acquired psychiatric disorder.

The Board denied service connection for bilateral hearing loss, a left ankle disability, and an initial compensable rating for pseudofolliculitis barbae of the face. The claims for service connection for various other disabilities were remanded.

The Board denied service connection for aortic valve disease, ischemic heart disease (IHD), and hypertension as the evidence did not support a finding that these conditions began during or are related to active service. The claims for squamous cell carcinoma and chloracne were remanded for further development.

The Board granted service connection for obstructive sleep apnea but denied service connection for chronic fatigue syndrome, chronic headaches, iritis of the bilateral eyes, and dermatitis of the bilateral feet.

The Board granted service connection for seborrheic dermatitis affecting the scalp, face, left arm, and torso but denied service connection for actinic keratosis on the nose and nonmelanoma skin cancer on the nose.

The Board remands the claim for service connection for pseudofolliculitis barbae (PFB) to schedule a VA examination.

The Board granted service connection for left shoulder strain, bilateral tinnitus, generalized anxiety disorder (to include depressive disorder due to medical condition), and left foot tinea pedis. The Board also granted a 20 percent evaluation for the left shoulder strain but denied service connection for right lateral lower extremity radiculopathy and bilateral hearing loss.

The Board denied service connection for left and right ankle disabilities, as well as effective dates prior to certain dates for dermatitis, IBS, and allergic rhinitis.

The Board denied service connection for aortic valve disease, ischemic heart disease (IHD), and hypertension as the evidence did not support a finding that these conditions began during or are related to active service. The claims for squamous cell carcinoma, chloracne, and chronic inflammatory demyelinating polyneuropathy were remanded for further development.

The Board denied service connection for bilateral hearing loss, an increased rating for generalized anxiety disorder with depression (GAD), and a compensable rating for pseudofolliculitis barbae. The claims for service connection for chronic left knee pain, chronic right knee pain, low back pain, neurogenic erectile dysfunction, onychomycosis, and pain and dysfunction of the right shoulder were remanded.

The Board denied service connection for lumbar strain with thoracolumbar scoliosis and a compensable rating for bilateral hearing loss.

The Board granted service connection for sinusitis pursuant to the PACT Act and granted a 70 percent rating for PTSD, while denying service connection for bilateral hearing loss, cervical strain, right ulnar nerve disability, right wrist disability, dermatitis, RLS, CFS, and a higher rating for an abdominal disorder.

The Board denied earlier effective dates for service connection and ratings for various conditions, granted an earlier effective date for left knee instability, and granted TDIU and DEA eligibility on and after April 27, 2021.

The Board remands the claim for an initial compensable disability rating for dermatitis to obtain a more adequate VA examination.

The Board granted service connection for an unspecified anxiety disorder and denied a rating in excess of 0 percent for seborrheic dermatitis of the forehead. The claim for chronic headaches was remanded.

The Board granted service connection for pseudofolliculitis barbae, finding that the evidence was in approximate balance to support a link between the condition and the Veteran's service.

The Board remands the claim for an initial disability rating in excess of 10 percent for eczema and chronic urticaria due to inadequate examination reports and potential outstanding treatment records.

The Board granted service connection for psoriasis and lumbosacral strain, but remanded the claim for an acquired psychiatric disorder due to a lack of adequate evidence.

The appeal for entitlement to accrued benefits was dismissed, and the claims for service connection were remanded.